- Home
- TOL vs ASND Comparison
TOL vs ASND Comparison
Compare TOL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOL | ASND |
|---|---|---|
| Founded | 1967 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 13.6B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TOL | ASND |
|---|---|---|
| Price | $153.46 | $242.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 15 |
| Target Price | $163.44 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 1.2M | 789.7K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.19 | N/A |
| Revenue | ★ $7,143,258,000.00 | N/A |
| Revenue This Year | N/A | $98.02 |
| Revenue Next Year | $7.86 | $43.13 |
| P/E Ratio | $70.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $86.67 | $124.06 |
| 52 Week High | $168.36 | $248.60 |
Technical Indicators
Market Signals| Indicator | TOL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 62.78 |
| Support Level | $133.98 | $190.49 |
| Resistance Level | $168.36 | $242.00 |
| Average True Range (ATR) | 4.97 | 10.28 |
| MACD | -1.43 | 1.30 |
| Stochastic Oscillator | 23.99 | 81.49 |
Price Performance
Historical ComparisonAbout TOL Toll Brothers Inc.
Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.